CA 125 secretion by peritoneal mesothelial cells.
Open Access
- 1 March 1994
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 47 (3), 263-265
- https://doi.org/10.1136/jcp.47.3.263
Abstract
AIMS--To investigate the secretion of the tumour marker CA 125 by cultured human mesothelial cells; to determine if secretion of CA 125 could be observed by activating the mesothelial monolayers with different cytokines. METHODS--Mesothelial cells were isolated from human omentum and cultured to confluent monolayers on perforated polycarbonate membranes (pore size 0.4 micron). The mesothelial monolayers were activated and the apical and basolateral secretion of CA 125 compared. To investigate the influence of cytokines, mesothelial cells were cultured and activated with recombinant interleukin-1 beta (rIL-1 beta), tumour necrosis factor-alpha (TNF-alpha) or lipopolysaccharide from Escherichia coli. The secretion of CA 125 was tested using a microparticle enzyme immunoassay. RESULTS--Mesothelial monolayers secreted CA 125 in a polarised manner with preference for the apical side. Apical polarisation occurred irrespective of the side of the inducing stimulus (p < or = 0.05). Non-activated cultured mesothelial monolayers secreted significant quantities of CA 125, indicating constitutive production of this protein. However, CA 125 production was significantly enhanced if mesothelial cells were incubated with rIL-1 beta (p < or = 0.05), TNF-alpha (p < or = 0.05), and E coli LPS (p < or = 0.01). CONCLUSIONS--Human mesothelial monolayers secrete CA 125 preferentially from their apical surfaces. The secretion of CA 125 can be enhanced by the inflammatory cytokines Il-1 beta, TNF-alpha, and by E coli LPS.Keywords
This publication has 17 references indexed in Scilit:
- Cancer antigen 125 in serum and ascitic fluid of patients with liver diseasesClinical Chemistry, 1991
- Serum CA 125 levels during the menstrual cycleBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerGynecologic Oncology, 1990
- New Concepts in Molecular Biology and Ultrastructural Pathology of the Peritoneum: Their Significance for Peritoneal DialysisAmerican Journal of Kidney Diseases, 1990
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.JCI Insight, 1989
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Regulation of the cytoskeleton in mesothelial cells: Reversible loss of keratin and increase in vimentin during rapid growth in cultureCell, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- The mesothelial keratins: A new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epitheliaCell, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981